Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2026)

Tonix Pharmaceuticals Holding's Inventory history runs 4 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• On a quarterly basis, Inventory fell 55.2% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $3.6 million, a 55.2% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 88.11% from the prior year.
• Inventory rose to $3.6 million in Q1 2026 per TNXP's latest filing, from $1.0 million in the prior quarter.
• Across five years, Inventory topped out at $13.7 million in Q2 2023 and bottomed at $339000.0 in Q3 2024.
• The 4-year median for Inventory is $7.1 million (2025), against an average of $6.9 million.
• Across the five-year window, Inventory slumped 97.46% in 2024 and soared 1589.97% in 2025, its largest moves.
• Year by year, Inventory stood at $508000.0 in 2023, then surged by 1555.12% to $8.4 million in 2024, then sank by 88.11% to $1.0 million in 2025, then surged by 264.5% to $3.6 million in 2026.
• Per Business Quant, the three latest TNXP Inventory figures stand at $3.6 million (Q1 2026), $1.0 million (Q4 2025), and $5.7 million (Q3 2025).